Asno04, A Novel 5t4-Targeted Dolaflexin Adc, Causes Complete And Durable Tumor Regression In A Variety Of Tumor Xenograft ModelsRoger A. Smith,David J. Zammit,Sanjeeva P. ReddyMOLECULAR CANCER THERAPEUTICS（2018）引用 1|浏览0暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
